Such findings indicate the potential of circulating miRNA expression in the blood as a complementary tool to PSA measurements both in diagnosis and during treatment and highlight the complex roles of miRNAs in the development of resistance to antiandrogen and taxane therapies in PCa. Here, KLK3 is linked to posterior cortical atrophy.